Skip to main content
VCbacked
Log inGet Started

Complement Therapeutics

London, United Kingdom

Complement Therapeutics operates as a preclinical stage company.

$78.7M raised
Apr 2023
Series A
BiotechnologyMedical

Top Investors

Cambridge Innovation CapitalForbion Capital PartnersBioGeneration VenturesPanakes PartnersHadean Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Complement Therapeutics

How much funding has Complement Therapeutics raised?
Complement Therapeutics has raised $78.7M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
Who are Complement Therapeutics's investors?
Complement Therapeutics's investors include Cambridge Innovation Capital, Forbion Capital Partners, BioGeneration Ventures, Panakes Partners, Hadean Ventures.
Where is Complement Therapeutics headquartered?
Complement Therapeutics is headquartered in London, United Kingdom.
What does Complement Therapeutics do?
Complement Therapeutics operates as a preclinical stage company.
What stage is Complement Therapeutics at?
Complement Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Complement Therapeutics — Funding & Investors." VCBacked, April 17, 2023, https://www.vcbacked.co/company/complement-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2023). Complement Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/complement-therapeutics
Wikipedia (cite web)
{{cite web |title=Complement Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/complement-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K